Predict your next investment

Santa Lucia Pharma Apps company logo
Corporation
SOFTWARE (NON-INTERNET/MOBILE) | Healthcare Software
slpa.eu

See what CB Insights has to offer

Stage

Acq - Fin | Alive

About Santa Lucia Pharma Apps

SLPA is a provider of advanced services to hospitals, offering integrated turn-key solutions to hospitals for the traceability and management of unit dose drugs and medical devices. SLPA solutions, which include proprietary software, patented robotic technologies and specialist support services, enable drugs and medical devices management from digital prescription to automated personalized unit dose treatment, up to software controlled administration to patients.

Santa Lucia Pharma Apps Headquarter Location

Piacenza,

Italy

+39 0523 785311

Latest Santa Lucia Pharma Apps News

October 22, 2018 - H.I.G. Capital Portfolio Company, Santa Lucia Pharma Apps, Acquires French...

Jan 30, 2019

Capital (“H.I.G.”), a leading global private equity investment firm with more than €24 billion of equity capital under management, announced today that its portfolio company Santa Lucia Pharma Apps S.r.l. (“SLPA”) has completed the acquisition of a controlling stake in Eco-dex SaS (“Eco-dex”), a leader in the production and commercialization of devices for the automated distribution of solid-oral drugs in the French market. Established in 2010 and headquartered in Le Mans (France), Eco-dex specializes in providing complete solutions for the automated management of drug logistics, in single-dose format, in healthcare and hospital facilities. Eco-dex, provides highly innovative machinery, based on proprietary technologies, and long-term assistance services that ensure maximum traceability of medicines, total security of doses and greater efficiency of consumption with a consequent significant reduction in medical spending. Eco-dex has a leading position in the French market, with an estimated market share of over 60% and installations in over 20 of the largest hospitals in France. acquired SLPA in July 2017 with the goal to provide the company and its management with the financial resources, as well as the experience and network, to support the internationalization process of the company, already a leader in the Italian market. Giorgio Pavesi, President of SLPA, commented: "The acquisition of Eco-dex represents a relevant step towards the extension of the product portfolio, thanks to the highly complementary technologies developed by the two companies, and the improvement in service offered to our customers for whom we can formulate increasingly customized solutions." Loïc Bessin, President of Eco-dex, said: "Joining the SLPA group is an important milestone for us, allowing us to move beyond national borders and to offer a broader portfolio of solutions to our clients worldwide." Raffaele Legnani, Managing Director of H.I.G. Europe, added: "H.I.G. is pleased to team-up with SLPA and its management team to support the group's international growth. Thanks to this acquisition and the strong organic growth achieved in recent years, the company enjoys a prominent position in the European market." SLPA was assisted by Next! Financial Advisor and by the law firm UGGC Avocats. About SLPA SLPA is one of the leading Italian providers of advanced services to hospitals, offering integrated turn-key solutions to hospitals for the traceability and management of unit dose drugs and medical devices. SLPA solutions, which include proprietary software, patented robotic technologies and specialist support services, enable drugs and medical devices management from digital prescription to automated personalized unit dose treatment, up to software controlled administration to patients. Based in Piacenza (60km from Milan, Italy), SLPA currently manages and delivers medicines to over 10,000 beds in 25 Italian hospitals, including some major university hospitals and highly respected and innovative centers. About Eco-dex Established in 2010 and headquartered in Le Mans (France), Eco-dex specializes in providing complete solutions for the automated management of drug logistics, in single-dose format, in healthcare and hospital facilities. Eco-dex has a leading position in the French market, with an estimated market share of over 60% and installations in over 20 of the largest hospitals in France. About H.I.G. Capital H.I.G. Capital is a leading global private equity and alternative assets investment firm with over €24 billion of equity capital under management. * Based in Miami, and with offices in New York, Boston, Chicago, Dallas, Los Angeles, San Francisco, and Atlanta in the U.S., as well as international affiliate offices in London, Hamburg, Madrid, Milan, Paris, Bogotá, Mexico City, Rio de Janeiro and São Paulo, H.I.G. specializes in providing both debt and equity capital to small and mid-sized companies, utilizing a flexible and operationally focused/ value-added approach: H.I.G.’s. equity funds invest in management buyouts, recapitalisations and corporate carve-outs of both profitable as well as underperforming manufacturing and service businesses. H.I.G.’s debt funds invest in senior, unitranche and junior debt financing to companies across the size spectrum, both on a primary (direct origination) basis, as well as in the secondary markets. is also a leading CLO manager, through its WhiteHorse family of vehicles, and manages a publicly traded BDC, WhiteHorse Finance. H.I.G.’s real assets funds invest in value-added properties, which can benefit from improved asset management practices. Since its founding in 1993, H.I.G. has invested in and managed more than 300 companies worldwide. The firm's current portfolio includes more than 100 companies with combined sales in excess of €28 billion. For more information, please refer to the H.I.G. website at www.higcapital.com . * Based on total capital commitments managed by H.I.G. Capital and affiliates.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Santa Lucia Pharma Apps

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Santa Lucia Pharma Apps is included in 2 Expert Collections, including Pharma Supply Chain.

P

Pharma Supply Chain

1,258 items

D

Digital Health

11,292 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Santa Lucia Pharma Apps Patents

Santa Lucia Pharma Apps has filed 2 patents.

The 3 most popular patent topics include:

  • Barcodes
  • Clusters of differentiation
  • Geodesy
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/4/2017

11/24/2020

Barcodes, Pharmaceutical industry, Linkages (mechanical), Clusters of differentiation, Geodesy

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

4/4/2017

00/00/0000

Grant Date

11/24/2020

00/00/0000

Title

Subscribe to see more

Related Topics

Barcodes, Pharmaceutical industry, Linkages (mechanical), Clusters of differentiation, Geodesy

Subscribe to see more

Status

Grant

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.